Search
for
Sort by
Research 751–780 of 1000+
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- O-21 FROM ORAL LEVOTHYROXINE RESISTANCE TO INTRAVENOUS LEVOTHYROXINE HYPERSENSITIVITY: A CHALLENGING PRIMARY HYPOTHYROIDISM CASE
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Review on Diagnostic and Managerial Consequences of PCOS Among Females
- Effect of oral minoxidil 1 mg and 2.5 mg on the growth speed of hair and nails
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- An Overview of Harmful Effects of Polycystic Ovary Syndrome
- The Siblings with Blistered Legs: Marking Nut Maladies in India
- Cirmcumscribed juvenile pityriasis rubra pilaris in a 5-year-old-girl treated with topical keratolytic and steroid
- Steroid Hormones of Reproduction and Sexual Development
- Operational research on the correlation between skin diseases and HIV infection in Tigray region, Ethiopia
- Former finasteride users with sexual side effects at increased risk for depressive symptoms, suicidal thoughts
- Hormonal treatment of acne vulgaris: an update
- Pregnancy, hair loss, and the pill.
- Effects of anticonvulsant drugs on chromosomes.
- A falling out following minoxidil: Telogen effluvium
- Telogen effluvium in the new SARS‐CoV‐2 era
- Alopecia Areata and Alopecia Areata Incognita
- Anaesthetics and platelets.
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- Effect of Oral Minoxidil on Monilethrix
- A Scarless Healing Tale: Comparing Homeostasis and Wound Healing of Oral Mucosa With Skin and Oesophagus
- Dermatological drugs, topical agents, and cosmetics
- Hirsutism and virilization
- Folliculitis decalvans: a multicentre review of 82 patients
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- The diagnosis and treatment of iron deficiency and its potential relationship to hair loss
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Dermatological adverse events with taxane chemotherapy
- Folliculitis decalvans